Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers

por Wang, Shiqi, Wang, Jinwan, Zhu, Mark Xuefang, Tan, Qian
Publicado 2022

Scalp metastasis from gastric cancer: A case report and literature review

por DU, CHUNXIA, HONG, RUOXI, LIU, YUEHUA, WANG, JINWAN, ZHANG, HONGGANG, YU, XIAODUO
Publicado 2015

Risk Prediction of Major Adverse Cardiovascular Events Occurrence Within 6 Months After Coronary Revascularization: Machine Learning Study

por Wang, Jinwan, Wang, Shuai, Zhu, Mark Xuefang, Yang, Tao, Yin, Qingfeng, Hou, Ya
Publicado 2022

Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: An open-label, phase I dose escalation and dose expansion trial

por Song, Yan, Wang, Jinwan, Ren, Xiubao, Jin, Jie, Mao, Li, Liang, Chris, Ding, Lieming, Yang, Lin
Publicado 2021

Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer

por YANG, LIN, YANG, YI, QIN, QIONG, ZHOU, AIPING, ZHAO, JIANJUN, WANG, JINWAN, SHU, CHANG, YUAN, XINGHUA, HU, SONGNIAN
Publicado 2015

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

por Sun, Yongkun, Niu, Wei, Du, Feng, Du, Chunxia, Li, Shuting, Wang, Jinwan, Li, Li, Wang, Fengqing, Hao, Yu, Li, Chuan, Chi, Yihebali
Publicado 2016

S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial

por Du, Feng, Zheng, Zhaoxu, Shi, SuSheng, Jiang, Zhichao, Qu, Tao, Yuan, Xinhua, Sun, Yongkun, Song, Yan, Yang, Lin, Zhao, Jiuda, Wang, Jinwan, Chi, Yihebali
Publicado 2015

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II tr...

por Gong, Jifang, Liu, Tianshu, Fan, Qingxia, Bai, Li, Bi, Feng, Qin, Shukui, Wang, Jinwan, Xu, Nong, Cheng, Ying, Bai, Yuxian, Liu, Wei, Wang, Liwei, Shen, Lin
Publicado 2016

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies

por Sheng, Xinan, Jin, Jie, He, Zhisong, Huang, Yiran, Zhou, Aiping, Wang, Jinwan, Ren, Xiubao, Ye, Dingwei, Zhang, Xu, Qin, Shukui, Zhou, Fangjian, Wang, Binhui, Guo, Jun
Publicado 2020

Phase II study of S‐1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off

por Li, Jin, Xu, Ruihua, Xu, Jianming, Denda, Tadamichi, Ikejiri, Koji, Shen, Lin, Toh, Yasushi, Shimada, Ken, Kato, Takeshi, Sakai, Kenji, Yamamoto, Manabu, Mishima, Hideyuki, Wang, Jinwan, Baba, Hideo
Publicado 2017

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial

por Ma, Jianhui, Song, Yan, Shou, Jianzhong, Bai, Yuxian, Li, Hanzhong, Xie, Xiaodong, Luo, Hong, Ren, Xiubao, Liu, Jiyan, Ye, Dingwei, Bai, Xianzhong, Fu, Cheng, Qin, Shukui, Wang, Jinwan, Zhou, Ai-Ping
Publicado 2020

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind...

por Shen, Lin, Li, Jin, Xu, Jianming, Pan, Hongming, Dai, Guanghai, Qin, Shukui, Wang, Liwei, Wang, Jinwan, Yang, Zhenzhou, Shu, Yongqian, Xu, Ruihua, Chen, Lei, Liu, Yunpeng, Yu, Shiying, Bu, Lilian, Piao, Yongzhe
Publicado 2014

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced o...

por Wang, Jinwan, Xu, Ruihua, Li, Jian, Bai, Yuxian, Liu, Tianshu, Jiao, Shunchang, Dai, Guanghai, Xu, Jianming, Liu, Yunpeng, Fan, Nanfeng, Shu, Yongqian, Ba, Yi, Ma, Dong, Qin, Shukui, Zheng, Leizhen, Chen, Weichang, Shen, Lin
Publicado 2015

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

por Si, Xiaoyan, Wang, Jinwan, Cheng, Ying, Shi, Jianhua, Cui, Liying, Zhang, Helong, Huang, Yunchao, Liu, Wei, Chen, Lei, Zhu, Jiang, Zhang, Shucai, Li, Wei, Sun, Yan, Wang, Hanping, Zhang, Xiaotong, Wang, Mengzhao, Yang, Lin, Zhang, Li
Publicado 2020